To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited review of drugs and biological products to provide safer or more effective treatment for males or females, to amend the Public Health Service Act to enhance the consideration of sex differences in basic and clinical research, and for other purposes.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Representative for Tennessee's 5th congressional district. Democrat.
Last Updated: Apr 29, 2015
Length: 13 pages
Apr 29, 2015
114th Congress, 2015–2017
Died in a previous Congress
This bill was introduced on April 29, 2015, in a previous session of Congress, but was not enacted.
What stakeholders are saying
Jun 17, 2014
Earlier Version — Introduced
This activity took place on a related bill, H.R. 4879 (113th).
Apr 29, 2015
H.R. 2101 (114th) was a bill in the United States Congress.
This bill was introduced in the 114th Congress, which met from Jan 6, 2015 to Jan 3, 2017. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
Civic Impulse. (2018). H.R. 2101 — 114th Congress: Research for All Act of 2015. Retrieved from https://www.govtrack.us/congress/bills/114/hr2101
“H.R. 2101 — 114th Congress: Research for All Act of 2015.” www.GovTrack.us. 2015. February 22, 2018 <https://www.govtrack.us/congress/bills/114/hr2101>
|title=H.R. 2101 (114th)
|accessdate=February 22, 2018
|author=114th Congress (2015)
|date=April 29, 2015
|quote=Research for All Act of 2015